{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:38:12Z","timestamp":1782603492503,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00228-024-03750-1","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T16:02:20Z","timestamp":1726070540000},"page":"1923-1935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials"],"prefix":"10.1007","volume":"80","author":[{"given":"Husam Abu","family":"Suilik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Saad","family":"Al-shammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abu","family":"Suilik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal A.","family":"Naeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Nawlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuelazm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"4","key":"3750_CR1","first-page":"493","volume":"25","author":"D Colombo","year":"2011","unstructured":"Colombo D, Ammirati E (2011) Cyclosporine in transplantation - a history of converging timelines. J Biol Regul Homeost Agents 25(4):493\u2013504","journal-title":"J Biol Regul Homeost Agents"},{"key":"3750_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/S12055-021-01320-Z","volume":"38","author":"MV Subramani","year":"2022","unstructured":"Subramani MV, Pandit S, Gadre SK (2022) Acute rejection and post lung transplant surveillance. Indian J Thorac Cardiovasc Surg 38:271\u2013279. https:\/\/doi.org\/10.1007\/S12055-021-01320-Z","journal-title":"Indian J Thorac Cardiovasc Surg"},{"issue":"6","key":"3750_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2217\/BMM-2021-1013","volume":"16","author":"T de Silva","year":"2022","unstructured":"de Silva T, Voisey J, Hopkins P et al (2022) Markers of rejection of a lung allograft: State of the art. Biomark Med 16(6):483\u2013498. https:\/\/doi.org\/10.2217\/BMM-2021-1013","journal-title":"Biomark Med"},{"issue":"10","key":"3750_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/FPC.0B013E328364DB84","volume":"23","author":"JM Barbarino","year":"2013","unstructured":"Barbarino JM, Staatz CE, Venkataramanan R et al (2013) PharmGKB summary: Cyclosporine and tacrolimus pathways. Pharmacogenet Genomics 23(10):563\u2013585. https:\/\/doi.org\/10.1097\/FPC.0B013E328364DB84","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"3750_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ICVTS\/IVY355","volume":"28","author":"D Bennett","year":"2019","unstructured":"Bennett D, Fossi A, Marchetti L et al (2019) Postoperative acute kidney injury in lung transplant recipients. Interact Cardiovasc Thorac Surg 28(6):929\u2013935. https:\/\/doi.org\/10.1093\/ICVTS\/IVY355","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3750_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2022.1044817","author":"Q Kong","year":"2023","unstructured":"Kong Q, Gao N, Wang Y et al (2023) Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2022.1044817","journal-title":"Front Pharmacol"},{"key":"3750_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/JCM11195859","author":"A Boscolo","year":"2022","unstructured":"Boscolo A, Dell\u2019Amore A, Pettenuzzo T et al (2022) The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study. J Clin Med. https:\/\/doi.org\/10.3390\/JCM11195859","journal-title":"J Clin Med"},{"issue":"5","key":"3750_CR8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.transproceed.2008.11.016","volume":"41","author":"Y Fan","year":"2009","unstructured":"Fan Y, Xiao YB, Weng YG (2009) Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Transplant Proc 41(5):1821\u20131824. https:\/\/doi.org\/10.1016\/j.transproceed.2008.11.016","journal-title":"Transplant Proc"},{"key":"3750_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008817.PUB2","author":"L Penninga","year":"2013","unstructured":"Penninga L, Penninga EI, M\u00f8ller CH et al (2013) Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008817.PUB2","journal-title":"Cochrane Database Syst Rev"},{"key":"3750_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions. https:\/\/doi.org\/10.1002\/9781119536604","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions."},{"key":"3750_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/BMJ.N71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, The PRISMA et al (2020) statement: An updated guideline for reporting systematic reviews. The BMJ 2021:372. https:\/\/doi.org\/10.1136\/BMJ.N71","journal-title":"The BMJ"},{"key":"3750_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.L4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: A revised tool for assessing risk of bias in randomised trials. The BMJ. https:\/\/doi.org\/10.1136\/BMJ.L4898","journal-title":"The BMJ."},{"issue":"7651","key":"3750_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R et al (2008) What is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ 336(7651):995\u2013998. https:\/\/doi.org\/10.1136\/bmj.39490.551019.BE","journal-title":"BMJ"},{"key":"3750_CR14","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.4. The Cochrane Collaboration. 2020"},{"key":"3750_CR15","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J et al. User Manual for Trial Sequential Analysis (TSA). Copenhagen: Copenhagen Trial Unit, Centre for Clinical Intervention Research; 2011:1\u2013115. Available from: \nwww.ctu.dk\/tsa"},{"issue":"1","key":"3750_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-2600(23)00293-X","volume":"12","author":"G Dellgren","year":"2024","unstructured":"Dellgren G, Lund TK, Raivio P et al (2024) Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial. Lancet Respir Med 12(1):34\u201344. https:\/\/doi.org\/10.1016\/S2213-2600(23)00293-X","journal-title":"Lancet Respir Med"},{"issue":"10","key":"3750_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/J.HEALUN.2007.07.027","volume":"26","author":"RR Hachem","year":"2007","unstructured":"Hachem RR, Yusen RD, Chakinala MM et al (2007) A Randomized Controlled Trial of Tacrolimus Versus Cyclosporine After Lung Transplantation. J Heart Lung Transplant 26(10):1012\u20131018. https:\/\/doi.org\/10.1016\/J.HEALUN.2007.07.027","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"3750_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/J.HEALUN.2012.03.008","volume":"31","author":"H Treede","year":"2012","unstructured":"Treede H, Glanville AR, Klepetko W et al (2012) Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation. J Heart Lung Transplant 31(8):797\u2013804. https:\/\/doi.org\/10.1016\/J.HEALUN.2012.03.008","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"3750_CR19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1067\/MTC.2003.71","volume":"125","author":"A Zuckermann","year":"2003","unstructured":"Zuckermann A, Reichenspurner H, Birsan T et al (2003) Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 125(4):891\u2013900. https:\/\/doi.org\/10.1067\/MTC.2003.71","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"3750_CR20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/J.HEALUN.2015.08.003","volume":"34","author":"LH Lund","year":"2015","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY et al (2015) The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report - 2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34(10):1244\u20131254. https:\/\/doi.org\/10.1016\/J.HEALUN.2015.08.003","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"3750_CR21","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/01.TP.0000181161.60638.FA","volume":"80","author":"RR Hachem","year":"2005","unstructured":"Hachem RR, Khalifah AP, Chakinala MM et al (2005) The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 80(10):1406\u20131413. https:\/\/doi.org\/10.1097\/01.TP.0000181161.60638.FA","journal-title":"Transplantation"},{"issue":"7","key":"3750_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/S00228-019-02658-5","volume":"75","author":"DR Darley","year":"2019","unstructured":"Darley DR, Carlos L, Hennig S et al (2019) Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection. Eur J Clin Pharmacol 75(7):879\u2013888. https:\/\/doi.org\/10.1007\/S00228-019-02658-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"3750_CR23","first-page":"761","volume":"17","author":"NR Horning","year":"1998","unstructured":"Horning NR, Lynch JP, Sundaresan SR et al (1998) Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. J Heart Lung Transplant 17(8):761\u2013767","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"3750_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ccm.2011.02.008","volume":"32","author":"T Martinu","year":"2011","unstructured":"Martinu T, Pavlisko EN, Chen DF, Palmer SM (2011) Acute allograft rejection: cellular and humoral processes. Clin Chest Med 32(2):295\u2013310. https:\/\/doi.org\/10.1016\/j.ccm.2011.02.008","journal-title":"Clin Chest Med"},{"issue":"8","key":"3750_CR25","first-page":"795","volume":"16","author":"BM Meiser","year":"1997","unstructured":"Meiser BM, Uberfuhr P, Fuchs A et al (1997) Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. J Heart Lung Transplant 16(8):795\u2013800","journal-title":"J Heart Lung Transplant"},{"issue":"2 SUPPL.","key":"3750_CR26","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/J.TRANSPROCEED.2004.01.038","volume":"36","author":"BD Maes","year":"2004","unstructured":"Maes BD, Vanrenterghem YFC (2004) Cyclosporine: Advantages versus disadvantages vis-\u00e0-vis tacrolimus. Transpl Proc 36(2 SUPPL.):S40\u2013S49. https:\/\/doi.org\/10.1016\/J.TRANSPROCEED.2004.01.038","journal-title":"Transpl Proc"},{"key":"3750_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005161.PUB2","author":"EM Haddad","year":"2006","unstructured":"Haddad EM, McAlister VC, Renouf E et al (2006) Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005161.PUB2","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"3750_CR28","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/J.TRANSPROCEED.2004.08.070","volume":"36","author":"SJ Kim","year":"2004","unstructured":"Kim SJ, Lee KW, Lee DS et al (2004) Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. Transpl Proc 36(7):2098\u20132100. https:\/\/doi.org\/10.1016\/J.TRANSPROCEED.2004.08.070","journal-title":"Transpl Proc"},{"issue":"10","key":"3750_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","volume":"43","author":"CE Staatz","year":"2004","unstructured":"Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43(10):623\u2013653. https:\/\/doi.org\/10.2165\/00003088-200443100-00001","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3750_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DRJ, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481\u2013508. https:\/\/doi.org\/10.2215\/CJN.04800908","journal-title":"Clin J Am Soc Nephrol"},{"issue":"SUPPL. 1","key":"3750_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/NDT\/16.SUPPL_1.121","volume":"16","author":"JM Morales","year":"2001","unstructured":"Morales JM, Andres A, Rengel M et al (2001) Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. Nephrol Dial Transplant 16(SUPPL. 1):121\u2013124. https:\/\/doi.org\/10.1093\/NDT\/16.SUPPL_1.121","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3750_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1681\/ASN.2014080834","volume":"26","author":"MR Weir","year":"2015","unstructured":"Weir MR, Burgess ED, Cooper JE et al (2015) Assessment and management of hypertension in transplant patients. J Am Soc Nephrol 26(6):1248\u20131260. https:\/\/doi.org\/10.1681\/ASN.2014080834","journal-title":"J Am Soc Nephrol"},{"key":"3750_CR33","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.928858","author":"K Muta","year":"2021","unstructured":"Muta K, Kitamura M, Hidaka M et al (2021) Association between trough level of tacrolimus and change in estimated glomerular filtration rate 1 year after living donor liver transplantation. Ann Transplant. https:\/\/doi.org\/10.12659\/AOT.928858","journal-title":"Ann Transplant"},{"issue":"4","key":"3750_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","volume":"18","author":"DO Taylor","year":"1999","unstructured":"Taylor DO, Barr ML, Radovancevic B et al (1999) A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18(4):336\u2013345. https:\/\/doi.org\/10.1016\/S1053-2498(98)00060-6","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"3750_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/CPT.546","volume":"101","author":"HA Chakkera","year":"2017","unstructured":"Chakkera HA, Kudva Y, Kaplan B (2017) Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus. Clin Pharmacol Ther 101(1):114\u2013120. https:\/\/doi.org\/10.1002\/CPT.546","journal-title":"Clin Pharmacol Ther"},{"key":"3750_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003961.PUB2","author":"AC Webster","year":"2005","unstructured":"Webster AC, Taylor RR, Chapman JR et al (2005) Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003961.PUB2","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"3750_CR37","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1097\/00007890-199506150-00018","volume":"59","author":"K Tamura","year":"1995","unstructured":"Tamura K, Fujimura T, Tsutsumi T et al (1995) Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic \u03b2-cell. Transplantation 59(11):1606\u20131613. https:\/\/doi.org\/10.1097\/00007890-199506150-00018","journal-title":"Transplantation"},{"issue":"3","key":"3750_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00007890-199908150-00012","volume":"68","author":"CB Drachenberg","year":"1999","unstructured":"Drachenberg CB, Klassen DK, Weir MR et al (1999) Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68(3):396\u2013402. https:\/\/doi.org\/10.1097\/00007890-199908150-00012","journal-title":"Transplantation"},{"issue":"6","key":"3750_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5125\/JKAOMS.2023.49.6.311","volume":"49","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Myoung H, Kim SM (2023) Review of two immunosuppressants: tacrolimus and cyclosporine. J Korean Assoc Oral Maxillofac Surg 49(6):311\u2013323. https:\/\/doi.org\/10.5125\/JKAOMS.2023.49.6.311","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"issue":"62","key":"3750_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/HTA20620","volume":"20","author":"T Jones-Hughes","year":"2016","unstructured":"Jones-Hughes T, Snowsill T, Haasova M et al (2016) Immunosuppressive therapy for kidney transplantation in adults: A systematic review and economic model. Health Technol Assess 20(62):1\u2013594. https:\/\/doi.org\/10.3310\/HTA20620","journal-title":"Health Technol Assess"},{"key":"3750_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/J.TRIM.2022.101741","author":"K Yang","year":"2022","unstructured":"Yang K, Zhang M, Zhang B et al (2022) Systematic review and meta-analysis of calcineurin inhibitors on long-term prognosis of renal transplant patients. Transpl Immunol. https:\/\/doi.org\/10.1016\/J.TRIM.2022.101741","journal-title":"Transpl Immunol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T18:02:52Z","timestamp":1731434572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3750"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03750-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}